← Leaderboards
Veronica Galvan
Beth Israel Deaconess Medical Center
$3,316,681
Attributed
$6,486,243
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,138,114 · 10
VA$0 · 2
By mechanism
P30$5,088,136 · 3
RF1$3,973,346 · 2
P20$2,145,000 · 1
T32$1,302,439 · 1
R01$392,513 · 1
R21$186,680 · 1
Top collaborators
- Holly Van Remmen7 shared
- Peter J Hornsby3 shared
- Nicolas Musi3 shared
- Kathy R Magnusson2 shared
- Alexei Kourakine1 shared
- Benjamin Francis Miller1 shared
- William Edmund Sonntag1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- David M Eisenberg$5,700,345
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseAgingS Disease ModelCellsMouse ModelBrainExcisionMolecularDisease ProgressionPreventNeuronsEtiologyLinkBiology Of AgingAreaBlood VesselsGrantFunctional DisorderInnovationPathway InteractionsPathologyImmunotherapyGeroscience
Grant awards (32)
Cellular and Molecular Geroscience CoBRE: Phase 2$2,145,000
P20 · FY2025 · GM
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging$1,325,136
P30 · FY2025 · AG · contact PI
Program Enrichment Core$403,164
P30 · FY2025 · AG · contact PI
Pathogenic soluble aggregated tau as a driver of brain vascular dysfunction in Alzheimer's disease$0
I01 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging$1,060,578
P30 · FY2024 · AG · contact PI
Tau-induced astrocyte senescence in Alzheimer's disease$392,513
R01 · FY2024 · AG · contact PI
Program Enhancement Core$178,101
P30 · FY2024 · AG · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Pathogenic soluble aggregated tau as a driver of brain vascular dysfunction in Alzheimer's disease$0
I01 · FY2024 · VA · contact PI
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging$1,060,578
P30 · FY2023 · AG · contact PI
Pathogenic Tau Promotes Brain Vascular Dysfunction in Alzheimer's Disease$0
I01 · FY2023 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2023 · VA · contact PI
Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging$1,060,579
P30 · FY2022 · AG · contact PI
50th Annual Meeting of the American Aging Association$50,000
R13 · FY2022 · AG · contact PI
Pathogenic Tau Promotes Brain Vascular Dysfunction in Alzheimer's Disease$0
I01 · FY2022 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2022 · VA · contact PI
Training Grant on the Biology of Aging$448,002
T32 · FY2021 · AG
Pathogenic Tau Promotes Brain Vascular Dysfunction in Alzheimer's Disease$0
I01 · FY2021 · VA · contact PI
Pathogenic Tau Promotes Brain Vascular Dysfunction in Alzheimer's Disease$0
I01 · FY2021 · VA · contact PI
Tau-induced astrocyte senescence in Alzheimer's disease$1,322,207
RF1 · FY2020 · AG · contact PI
Training Grant on the Biology of Aging$437,103
T32 · FY2020 · AG
Tau-induced astrocyte senescence in Alzheimer's disease$322,245
RF1 · FY2020 · AG · contact PI
Pathogenic Tau Promotes Brain Vascular Dysfunction in Alzheimer's Disease$0
I01 · FY2020 · VA · contact PI
Training Grant on the Biology of Aging$417,334
T32 · FY2019 · AG
Brain cellular senescence as a driver of Alzheimers Disease$136,883
RF1 · FY2019 · AG · contact PI
Inhibiting the TOR Pathway to Combat Alzheimer's Disease$0
I01 · FY2018 · VA · contact PI
Brain cellular senescence as a driver of Alzheimers Disease$2,192,011
RF1 · FY2017 · AG · contact PI
Inhibiting the TOR Pathway to Combat Alzheimer's Disease$0
I01 · FY2017 · VA · contact PI
Inhibiting the TOR Pathway to Combat Alzheimer's Disease$0
I01 · FY2016 · VA · contact PI
Inhibiting the TOR Pathway to Combat Alzheimer's Disease$0
I01 · FY2015 · VA · contact PI
Proteomic analysis of Amyloid Precursor Protein signaling: mediators of toxicity$186,680
R21 · FY2008 · AG